NO20081314L - Anvendelse av azabicykloheksanderivater - Google Patents

Anvendelse av azabicykloheksanderivater

Info

Publication number
NO20081314L
NO20081314L NO20081314A NO20081314A NO20081314L NO 20081314 L NO20081314 L NO 20081314L NO 20081314 A NO20081314 A NO 20081314A NO 20081314 A NO20081314 A NO 20081314A NO 20081314 L NO20081314 L NO 20081314L
Authority
NO
Norway
Prior art keywords
disorder
nervosa
hyperchondriasis
sydeham
paraphilia
Prior art date
Application number
NO20081314A
Other languages
English (en)
Norwegian (no)
Inventor
Dieter Hamprecht
Christian Heidbreder
Sergio Melotto
Fabrizio Micheli
Tadataka Yamada
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20081314L publication Critical patent/NO20081314L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Psychology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)
NO20081314A 2005-08-22 2008-03-12 Anvendelse av azabicykloheksanderivater NO20081314L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0517193.9A GB0517193D0 (en) 2005-08-22 2005-08-22 Novel use
PCT/EP2006/008314 WO2007022980A1 (en) 2005-08-22 2006-08-21 Use of azabicyclo hexane derivatives

Publications (1)

Publication Number Publication Date
NO20081314L true NO20081314L (no) 2008-03-17

Family

ID=35098098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081314A NO20081314L (no) 2005-08-22 2008-03-12 Anvendelse av azabicykloheksanderivater

Country Status (20)

Country Link
US (2) US20090036461A1 (ko)
EP (1) EP1917013B1 (ko)
JP (1) JP5166267B2 (ko)
KR (1) KR101363090B1 (ko)
CN (1) CN101291669B (ko)
AT (1) ATE500826T1 (ko)
AU (1) AU2006284077B2 (ko)
BR (1) BRPI0614929A2 (ko)
CA (1) CA2620090A1 (ko)
CR (1) CR9807A (ko)
DE (1) DE602006020589D1 (ko)
EA (1) EA016084B1 (ko)
ES (1) ES2361933T3 (ko)
GB (1) GB0517193D0 (ko)
IL (1) IL189435A0 (ko)
MA (1) MA29774B1 (ko)
MX (1) MX2008002564A (ko)
NO (1) NO20081314L (ko)
WO (1) WO2007022980A1 (ko)
ZA (1) ZA200801352B (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200538113A (en) * 2004-02-23 2005-12-01 Glaxo Group Ltd Compounds
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
GB0507602D0 (en) * 2005-04-14 2005-05-18 Glaxo Group Ltd Compounds
GB0507601D0 (en) * 2005-04-14 2005-05-18 Glaxo Group Ltd Compounds
GB0512099D0 (en) * 2005-06-14 2005-07-20 Glaxo Group Ltd Compounds
ATE484502T1 (de) * 2005-06-14 2010-10-15 Glaxo Group Ltd Neue verbindungen
EP2719384B1 (en) 2005-07-27 2018-08-08 Otsuka America Pharmaceutical, Inc. Novel 1-naphthyl-3-azabicyclo[3.1.0]hexanes:preparation and use to treat neuropsychiatric disorders
GB0517187D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
GB0517175D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
GB0517191D0 (en) 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
US7799815B2 (en) * 2005-08-22 2010-09-21 Glaxo Group Limited Triazole derivatives as modulators of dopamine D3 receptors
US8163927B2 (en) * 2006-04-03 2012-04-24 Glaxo Group Limited Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors
JP5189076B2 (ja) * 2006-04-03 2013-04-24 グラクソ グループ リミテッド ドーパミンｄ３受容体のモジュレーターとしてのアザビシクロ［３．１．０］ヘキシル誘導体
GB0607899D0 (en) 2006-04-03 2006-05-31 Glaxo Group Ltd Process for preparing heterocyclic derivatives
US20080045725A1 (en) 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
GB0616574D0 (en) * 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds
US8138377B2 (en) 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
EP2167083B1 (en) * 2007-06-06 2015-10-28 Euthymics Bioscience, Inc. 1- heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
US9133159B2 (en) * 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
US8906913B2 (en) * 2009-06-26 2014-12-09 Panacea Biotec Limited Azabicyclohexanes
WO2012033956A1 (en) 2010-09-08 2012-03-15 Mithridion, Inc. Cognition enhancing compounds and compositions, methods of making, and methods of treating
US9314600B2 (en) 2012-04-15 2016-04-19 Bioconnect Systems, Inc. Delivery system for implantable flow connector
WO2019146740A1 (ja) 2018-01-26 2019-08-01 塩野義製薬株式会社 ドーパミンｄ３受容体拮抗作用を有する環式化合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI244481B (en) 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
US20020103198A1 (en) * 2000-12-04 2002-08-01 Fliri Anton F.J Acylamino cyclopropane derivatives
TW200538113A (en) * 2004-02-23 2005-12-01 Glaxo Group Ltd Compounds
SE526837C2 (sv) * 2004-02-24 2005-11-08 Kongsberg Automotive Asa Växelspakstransmission
CN101384263A (zh) * 2004-12-02 2009-03-11 艾博特股份有限两合公司 适合治疗对多巴胺d3受体调节产生反应的疾病的三唑化合物
GB0507602D0 (en) * 2005-04-14 2005-05-18 Glaxo Group Ltd Compounds
GB0507601D0 (en) * 2005-04-14 2005-05-18 Glaxo Group Ltd Compounds
GB0507680D0 (en) * 2005-04-15 2005-05-25 Glaxo Group Ltd Compounds
ATE484502T1 (de) * 2005-06-14 2010-10-15 Glaxo Group Ltd Neue verbindungen
GB0512099D0 (en) * 2005-06-14 2005-07-20 Glaxo Group Ltd Compounds
GB0517175D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
GB0517191D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
US7799815B2 (en) * 2005-08-22 2010-09-21 Glaxo Group Limited Triazole derivatives as modulators of dopamine D3 receptors
GB0517187D0 (en) * 2005-08-22 2005-09-28 Glaxo Group Ltd Compounds
JP5189074B2 (ja) * 2006-04-03 2013-04-24 グラクソ グループ リミテッド ドーパミンｄ３受容体のモジュレーターとしてのアザビシクロ［３．１．０］ヘキシル誘導体
GB0616574D0 (en) * 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
KR20080040022A (ko) 2008-05-07
US20090036461A1 (en) 2009-02-05
DE602006020589D1 (de) 2011-04-21
EA016084B1 (ru) 2012-02-28
EP1917013A1 (en) 2008-05-07
CA2620090A1 (en) 2007-03-01
ZA200801352B (en) 2009-01-28
US20120196910A1 (en) 2012-08-02
KR101363090B1 (ko) 2014-02-13
JP2009506989A (ja) 2009-02-19
CN101291669B (zh) 2012-09-26
EP1917013B1 (en) 2011-03-09
ATE500826T1 (de) 2011-03-15
JP5166267B2 (ja) 2013-03-21
AU2006284077A1 (en) 2007-03-01
CR9807A (es) 2008-07-29
ES2361933T3 (es) 2011-06-24
MX2008002564A (es) 2008-03-18
EA200800655A1 (ru) 2008-08-29
IL189435A0 (en) 2008-08-07
AU2006284077B2 (en) 2012-05-17
GB0517193D0 (en) 2005-09-28
CN101291669A (zh) 2008-10-22
BRPI0614929A2 (pt) 2011-04-19
WO2007022980A1 (en) 2007-03-01
MA29774B1 (fr) 2008-09-01

Similar Documents

Publication Publication Date Title
NO20081314L (no) Anvendelse av azabicykloheksanderivater
BRPI0413234A (pt) derivados de imidazola bicìclica contra flaviviridae
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
EP2041159B8 (en) Macrocyclic compounds as antiviral agents
EP2546246A3 (en) Compounds and methods for the treatment or prevention of flavivirus infections
HK1119699A1 (en) Pyridopyrimidinone inhibitors of pi3kalpha
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
EA201000050A1 (ru) Замещенные бициклолактамные соединения
ES2422557T3 (es) Compuestos y composiciones como moduladores de la ruta Hedgehog
GEP20094727B (en) Oxyindole derivatives as 5ht4 receptor agonists
HK1121440A1 (en) Biphenyl derivatives and their use in treating hepatitis c
MX2009001062A (es) Agonistas de ep2.
WO2010047737A3 (en) Antimicrobial indoline compounds for treatment of bacterial infections
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
IL191751A0 (en) Pyrrolo[2,3-c]pyridine derivatives
ATE368040T1 (de) Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase- inhibitoren
EA200800151A1 (ru) Производные хинолина в качестве антибактериальных агентов
EA201290229A1 (ru) Производные спиролактама и их применение
MXPA05008960A (es) Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen.
JO2999B1 (ar) مركب ثلاثي حلقي و استخدامه الدوائي
IL191928A0 (en) Triazoloanilinopyrimidine derivatives for use as antiviral agents
NO20080501L (no) Kinolinderivater som antibakterielle midler
WO2007027878A3 (en) 4-substituted 2-aryloxyphenol derivatives as antibacterial agents
EA200800152A1 (ru) Производные хинолина в качестве антибактериальных агентов
ATE465151T1 (de) 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: GLAXO GROUP LTD, GB

FC2A Withdrawal, rejection or dismissal of laid open patent application